trial · primary record
Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]
Hydrocephalus in Infants
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2028-09-01 |
| Primary endpoint | Feasibility of brain contrast-enhanced ultrasound (CEUS) examinations in infants with hydrocephalus |
| Registry ID | NCT06693752 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:54.285Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06693752
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.